News for IDEXX Laboratories, Inc. (0J8P.L)

IDEXX Laboratories Inc (IDXX) has recently been in the spotlight, drawing interest from investors and financial analysts due to its robust financial stance. Wit

Stifel has revised its price outlook for Idexx Laboratories (IDXX), decreasing the target from $450 to $420. This adjustment follows an in-depth survey evaluati

TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. In the fourth quarter, the strategy returned -1.35% (gross) and -1.56% (net) compared to 8.14% for the Russell Midcap Growth Index. In the fourth quarter, the U.S. small […]

IDEXX Laboratories Inc (IDXX), a prominent player in the pet healthcare innovation sector, has announced that it will release its financial results for the firs

[url="]IDEXX Laboratories, Inc.[/url] (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2025 first quarter financi

Today's Research Daily features new research reports on 16 major stocks, including The Walt Disney Co. (DIS), The Progressive Corp. (PGR) and Citigroup Inc. (C), as well as two micro-cap stocks Tucows Inc. (TCX) and Team, Inc. (TISI).

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take a look at where IDEXX Laboratories, Inc.

We came across a bullish thesis on IDEXX Laboratories, Inc. (IDXX) on Substack by Hidden Market Gems. In this article, we will summarize the bulls’ thesis on IDXX. IDEXX Laboratories, Inc.

The ClearBridge Mid Cap Growth Strategy performed in line with its Russell Midcap Growth Index benchmark during the fourth quarter. Click here to read the full commentary.

Shares of IDEXX Laboratories Inc (IDXX) fell 3.10% in mid-day trading on Feb 28. The stock reached an intraday low of $423.82, before recovering slightly to $

Robust product innovation and market leadership in veterinary diagnostics.Expansive global presence with a focus on enhancing veterinary practice efficiency.Ch

Baron WealthBuilder Fund, a compilation of Baron Funds, increased in the fourth quarter of 2024, outperforming its benchmark, the S&P 500 Index.

Baron Partners Fund increased in the fourth quarter of 2024, outperforming its benchmark, the Russell Midcap Growth Index.

Is IDEXX Laboratories a good investment? Analyzing its consistent growth, innovative products, and international expansion amidst recent challenges. Read the full stock report here.

IDEXX Laboratories is poised for growth in the pet healthcare market. Check out why I see a 50% upside in IDXX stock by FY27.

We recently published a list of Jim Cramer On 9 Stocks That Are Rallying Despite Tariff Worries. In this article, we are going to take a look at where IDEXX Laboratories, Inc.

On Monday, Jim Cramer, the host of Mad Money, told viewers that they should not be too surprised by President Donald Trump's decision to impose steep tariff hikes, a move Trump had promised during his...

Wall Street bounced back after President Donald Trump and Mexican President Claudia Sheinbaum agreed to a one-month suspension of tariffs following Mexico's pledge to bolster its military presence at the northern borde

IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2024 Earnings Conference Call February 3, 2025 8:30 AM ETCompany ParticipantsBrian McKeon - Chief Financial...